Drug Product
Excipients & Specialty Ingredients
Company Overview
About
KD Pharma Group is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Formulation Development, Process Development, Scale-up
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:Germany
Founded:2003
Employees:1,266
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 4 (1-10 µg/m³)
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
Global
Manufacturing Facilities
1 site worldwide
KD Pharma Canada LTD
39 England Avenue, Mulgrave, Nova Scotia B, 0E 2G0
Site Capabilities
2 capabilitiesMANUFACTURE
PACK
Regulatory Approvals
Drug Approval ISBGLE
PMDA · #APR-8ADY6U43 · 2021-10-01
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-X4L0F5JB
Issued: 2020-02-05
Expires: 2025-03-27
MHRA GMP
UK Medicines and Healthcare products Regulatory Agency
Cert #: CERT-CGWB5DQD
Issued: 2020-03-23
Expires: 2025-07-22
Loading CDMO intelligence...
Key facts about KD Pharma Group
- KD Pharma Group is headquartered in Germany.
- KD Pharma Group was founded in 2003.
- KD Pharma Group has 1,266 employees.
- KD Pharma Group has one manufacturing site listed on CDMO Hub, in Mulgrave, Canada.
- KD Pharma Group's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like KD Pharma Group
Directory pages this company appears in, each with the full list of matching manufacturers.